CMCollins M. Morang’a

Collins M. Morang’a

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Collins M. Morang’a has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genomic population structure and insecticide resistance mechanisms in the malaria vector An. coluzzii across contrasting bioclimatic zones in West Africa

    by Enock K. Amoako, Kelly L. Bennett, Anastasia Hernandez-Koutoucheva, Isaiah Debrah, Collins M. Morang’a, Stephen Binaansim, Victor A. Asoala, Cristina Ariana, Keziah L. Malm, Gordon Awandare, et al.

    Environmental barriers influencing the movement of insect vectors can govern adaptive gene flow, including the dispersal of insecticide resistance mechanisms that compromise population control. We sought to understand population connectivity of the major malaria vector, An. coluzzii , across the different bioclimatic zones of West Africa using SNPs from whole genomes and inversion karyotypes previously associated with environmental adaptation. We identified restricted gene flow between populations from northern savannah and southern forested regions. Using Ghana as a case study, we found marked differences in insecticide resistance profiles across the different bioclimatic zones suggesting that population connectivity impacts on adaptive allele sharing. Greater evidence for target site pyrethroid and metabolic cross-resistance in the North reflects differences in insecticide use across the country. We also observed distinct resistance mechanisms in the coastal region of Greater Accra which may result from intense urban agricultural activity. Overall, findings suggest that environmental conditions restrict An. coluzzii gene flow to impact the geographical distribution of molecular insecticide resistance.

  • Open Access

    Plasmodium falciparum Subtilisin-like Domain-Containing Protein (PfSDP), a Cross-Stage Antigen, Elicits Short-Lived Antibody Response Following Natural Infection with Plasmodium falciparum

    by Jonas A. Kengne-Ouafo, Collins M. Morang’a, Nancy K. Nyakoe, Daniel Dosoo, Richmond Tackie, Joe K. Mutungi, Saikou Y. Bah, Lucas N. Amenga-Etego, Britta Urban, Gordon A. Awandare, et al.

    With the increasing detection of artemisinin resistance to front-line antimalarials in Africa and notwithstanding the planned roll-out of RTS’S and R21 in Africa, the search for new vaccines with high efficacy remains an imperative. Towards this endeavour, we performed in silico screening to identify Plasmodium falciparum gametocyte stage genes that could be targets of protection or diagnosis. Through the analysis we identified a gene, Pf3D7_1105800, coding for a Plasmodium falciparum subtilisin-like domain-containing protein (PfSDP) and thus dubbed the gene Pfsdp. Genetic diversity assessment revealed the Pfsdp gene to be relatively conserved across continents with signs of directional selection. Using RT qPCR and Western blots, we observed that Pfsdp is expressed in all developmental stages of the parasite both at the transcript and protein level. Immunofluorescence assays found PfSDP protein co-localizing with PfMSP-1 and partially with Pfs48/45 at the asexual and sexual stages, respectively. Further, we demonstrated that anti-PfSDP peptide-specific antibodies inhibited erythrocyte invasion by 20–60% in a dose-dependent manner, suggesting that PfSDP protein might play a role in merozoite invasion. We also discovered that PfSDP protein is immunogenic in children from different endemic areas with antibody levels increasing from acute infection to day 7 post-treatment, followed by a gradual decay. The limited effect of antibodies on erythrocyte invasion could imply that it might be more involved in other processes in the development of the parasite.

  • Open Access

    Plasmodium falciparum Subtilisin-Like Domain Containing Protein ((PfSDP) PF3D7_1105800), a Cross-Stage Antigen, Elicits Short-Lived Antibody Response Following Natural Infection with Plasmodium falciparum

    by Jonas Arnaud Kengne-Ouafo, Collins M Morang'A, Nancy K Nyakoe, Daniel Dosoo, Richmond Tackie, Joe Mutungi, Saikou Y Bah, Lucas Amenga-Etego, Britta C. Urban, Gordon A. Awandare, et al.

    With the increasing detection of artemisinin resistance to front-line antimalarials in Africa and notwithstanding the planned roll-out of RTS’S and R21 in Africa, the search for new vaccines with high efficacy remains an imperative. Towards this endeavor, we performed in silico screening to identify Plasmodium falciparum gametocyte stage genes that could be targets of protection or diagnosis. Through the analysis, we identified a gene, Pf3D7_1105800, coding for a Plasmodium falciparum subtilisin-like do-main-containing protein (PfSDP). Genetic diversity assessment revealed the Pfsdp gene to be relatively conserved across continents with signs of directional selection. Using RT qPCR and western blots, we observed that Pfsdp is expressed in all parasite developmental stages at the transcript and protein levels. Immunofluorescence assays found PfSDP protein colocalizing with PfMSP-1 and partially with Pfs48/45 at the asexual and sexual stages, respectively. Further, we demonstrated that anti-PfSDP peptide-specific antibodies inhibited erythrocyte invasion by 20-60% in a dose-dependent manner, suggesting that PfSDP protein might play a role in merozoites invasion. We also discovered that PfSDP protein is immunogenic in children from different endemic areas with antibody level increasing from acute infection to day 7 post-treatment, followed by a gradual decay. The limited effect of antibodies on erythrocyte invasion could imply that it might be more involved in other processes in the development of the parasite.